4 Interim decisions on proposed amendments referred to the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS #25, June 2020)
4.2 Interim decision in relation to isothiazolinones, methylisothiazolinone and methylchloroisothiazolinones
A Delegate of the Secretary has made a decision to defer the interim decision for isothiazolinones, methylisothiazolinone and methylchloroisothiazolinones, until June 2021. This is to allow for further consideration of appropriate cut-offs and for consultation with key stakeholders that will be affected by any change in the scheduling of these substances. The Joint ACMS-ACCS #25 was in support of this decision.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.